FAP-targeted [(68)Ga]BED003-PET compared with [(18)F]DOPA-PET in patients with recurrent medullary thyroid carcinoma.

Journal: Frontiers in nuclear medicine •

Abstract

Abstract text is not embedded in this discovery record. Please consult the full-text publication via the source link on the right.

Subjects & Keywords

How to Cite this Article

Ventura D, Noto B, Backhaus P, et al. (2026). "FAP-targeted [(68)Ga]BED003-PET compared with [(18)F]DOPA-PET in patients with recurrent medullary thyroid carcinoma.". Frontiers in nuclear medicine. https://doi.org/10.3389/fnume.2026.1949036